Valuation: Balchem Corporation

Market Cap 5.39B 4.89B 4.52B 4.08B 7.7B 504B 7.99B 54.47B 21.54B 272B 20.22B 19.8B 859B P/E 2026 *
31x
P/E 2027 * 29.7x
Enterprise Value 5.44B 4.94B 4.56B 4.12B 7.77B 508B 8.07B 54.97B 21.74B 274B 20.41B 19.98B 867B EV / Sales 2026 *
4.8x
EV / Sales 2027 * 4.47x
Free-Float
99.41%
Yield 2026 *
0.7%
Yield 2027 * 0.78%
1 day-0.06%
1 week-2.49%
Current month-0.59%
1 month-0.85%
3 months-4.53%
6 months+5.96%
Current year+10.18%
1 week 167.84
Extreme 167.84
175.5
1 month 165.77
Extreme 165.77
186.15
Current year 152.58
Extreme 152.58
186.15
1 year 147.18
Extreme 147.18
186.15
3 years 120.76
Extreme 120.76
186.15
5 years 110.15
Extreme 110.1456
186.15
10 years 70.23
Extreme 70.23
186.15
Manager TitleAgeSince
Chief Executive Officer 61 27/04/2015
Director of Finance/CFO 49 03/02/2019
Chief Tech/Sci/R&D Officer 56 30/09/2025
Director TitleAgeSince
Director/Board Member 63 15/09/2010
Chairman 61 31/12/2016
Director/Board Member 59 14/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Controller/Auditor

8,646 0.0270%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%-2.49%+9.75%+36.19% 5.39B
-0.61%-2.53%+17.36%+62.21% 84.87B
+0.52%+0.20%+24.00%+25.99% 44.83B
-0.42%+0.39%+26.53%+25.88% 36.96B
+0.25%-2.37%+27.97%-19.37% 36.22B
-0.09%-0.55%+12.42%+24.65% 30.99B
0.00%+4.44%+9.62%+22.23% 27.2B
-0.12%-1.30%+57.10%+34.89% 23.32B
-0.04%-3.77%+28.98%-30.05% 19.9B
-5.41%-11.07%-18.05%-7.35% 14.74B
Average -0.61%+0.14%+19.57%+17.53% 32B
Weighted average by Cap. -0.37%+0.41%+21.22%+25.80%

Financials

2026 *2027 *
Net sales 1.13B 1.03B 949M 857M 1.62B 106B 1.68B 11.44B 4.53B 57.08B 4.25B 4.16B 180B 1.2B 1.09B 1.01B 907M 1.71B 112B 1.78B 12.12B 4.79B 60.46B 4.5B 4.4B 191B
Net income 176M 160M 148M 133M 251M 16.44B 261M 1.78B 703M 8.87B 660M 646M 28.03B 184M 167M 155M 139M 263M 17.23B 273M 1.86B 737M 9.3B 692M 677M 29.37B
Net Debt 49.61M 45.04M 41.61M 37.53M 70.86M 4.64B 73.57M 501M 198M 2.5B 186M 182M 7.9B -27.03M -24.54M -22.67M -20.45M -38.6M -2.53B -40.08M -273M -108M -1.36B -101M -99.27M -4.31B
Projected Income Statement - Annual - Balchem Corporation
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,430
Date Price Change Volume
18/11/26 US$168.98 -0.38% 20,149
17/11/26 US$169.63 -1.08% 160,306
16/11/26 US$171.48 -0.96% 168,283
13/11/26 US$173.14 +0.46% 144,013
12/11/26 US$172.35 -0.55% 178,678
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Balchem Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
169.63USD
Average target price
213.50USD
Spread / Average Target
+25.86%
  1. Stock Market
  2. Stocks
  3. BCPC Stock